Lanthanum carbonate 500 MG Chewable Tablet — RxCUI 477347
RxNorm drug concept · Semantic clinical drug
RxCUI 477347
Semantic clinical drug · SCD
● Current RxNorm concept 23 FDA products
23 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI477347
Official nameLanthanum carbonate 500 MG Chewable Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped23
Package NDCs mapped23
Reported Medicaid activity (SDUD)4,990 prescriptions · 21 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How Lanthanum carbonate 500 MG Chewable Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Lanthanum carbonate 500 MG Chewable Tablet
RxCUI 477347 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Lanthanum carbonate
234416IN
-
Lanthanum carbonate
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Fosrenol
356761BN
-
Fosrenol
-
Dose forms 12
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Lanthanum carbonate Chewable Tablet
477346SCDF -
Lanthanum carbonate Chewable Product
1295457SCDG -
Lanthanum carbonate Oral Product
1162547SCDG -
Lanthanum carbonate Pill
1162548SCDG -
Lanthanum carbonate Chewable Tablet [Fosrenol]
542462SBDF -
Fosrenol Chewable Product
1296569SBDG -
Fosrenol Oral Product
1173292SBDG -
Fosrenol Pill
1173293SBDG - +4 more in this family
-
Lanthanum carbonate Chewable Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Lanthanum carbonate 500 MG
477348SCDC -
Lanthanum carbonate 500 MG Chewable Tablet [Fosrenol]
542465SBD -
Lanthanum carbonate 500 MG [Fosrenol]
542464SBDC
-
Lanthanum carbonate 500 MG
Showing up to 8 concepts per family — 13 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Lanthanum carbonate 500 MG
SCDC · 477348 -
Lanthanum carbonate Chewable Tablet
SCDF · 477346 -
Lanthanum carbonate Chewable Product
SCDG · 1295457 -
Lanthanum carbonate Oral Product
SCDG · 1162547 -
Lanthanum carbonate Pill
SCDG · 1162548
Brand-Name Concepts
-
Lanthanum carbonate 500 MG Chewable Tablet [Fosrenol]
SBD · 542465 -
Lanthanum carbonate 500 MG [Fosrenol]
SBDC · 542464 -
Lanthanum carbonate Chewable Tablet [Fosrenol]
SBDF · 542462 -
Fosrenol Chewable Product
SBDG · 1296569 -
Fosrenol Oral Product
SBDG · 1173292 -
Fosrenol Pill
SBDG · 1173293 -
Fosrenol
BN · 356761
📦 FDA Products & Package NDCs
23 products · 23 package NDCs
23 package NDCs map to RxCUI 477347 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00093-5938-98 | 2 BOTTLE in 1 CARTON (0093-5938-98) / 45 TABLET, CHEWABLE i... | Lanthanum carbonate | Teva Pharmaceuticals USA, Inc. | 2022-05-25 |
| 00093-5939-98 | 6 BOTTLE in 1 CARTON (0093-5939-98) / 15 TABLET, CHEWABLE i... | Lanthanum carbonate | Teva Pharmaceuticals USA, Inc. | 2022-05-25 |
| 00093-5940-98 | 9 BOTTLE in 1 CARTON (0093-5940-98) / 10 TABLET, CHEWABLE i... | Lanthanum carbonate | Teva Pharmaceuticals USA, Inc. | 2022-05-25 |
| 54092-0252-90 | 2 BOTTLE in 1 PACKAGE (54092-252-90) / 45 TABLET, CHEWABLE... | Fosrenol | Takeda Pharmaceuticals America, Inc. | 2004-10-26 |
| 54092-0253-90 | 6 BOTTLE in 1 PACKAGE (54092-253-90) / 15 TABLET, CHEWABLE... | Fosrenol | Takeda Pharmaceuticals America, Inc. | 2005-11-23 |
| 54092-0254-90 | 9 BOTTLE in 1 PACKAGE (54092-254-90) / 10 TABLET, CHEWABLE... | Fosrenol | Takeda Pharmaceuticals America, Inc. | 2005-11-23 |
| 54092-0256-02 | 9 CARTON in 1 PACKAGE (54092-256-02) / 10 POWDER in 1 CARTO... | Fosrenol | Takeda Pharmaceuticals America, Inc. | 2014-09-24 |
| 54092-0257-02 | 9 CARTON in 1 CARTON (54092-257-02) / 10 POWDER in 1 CARTON... | Fosrenol | Takeda Pharmaceuticals America, Inc. | 2014-09-24 |
| 66993-0422-85 | 2 BOTTLE in 1 PACKAGE (66993-422-85) / 45 TABLET, CHEWABLE... | Lanthanum carbonate | Prasco Laboratories | 2017-08-30 |
| 66993-0423-85 | 6 BOTTLE in 1 PACKAGE (66993-423-85) / 15 TABLET, CHEWABLE... | Lanthanum carbonate | Prasco Laboratories | 2017-08-30 |
| 66993-0424-85 | 9 BOTTLE in 1 PACKAGE (66993-424-85) / 10 TABLET, CHEWABLE... | Lanthanum carbonate | Prasco Laboratories | 2017-08-30 |
| 67877-0256-90 | 2 BOTTLE in 1 CARTON (67877-256-90) / 45 TABLET, CHEWABLE i... | Lanthanum Carbonate | Ascend Laboratories, LLC | 2025-05-10 |
| 67877-0257-90 | 6 BOTTLE in 1 CARTON (67877-257-90) / 15 TABLET, CHEWABLE i... | Lanthanum Carbonate | Ascend Laboratories, LLC | 2025-05-10 |
| 67877-0258-90 | 9 BOTTLE in 1 CARTON (67877-258-90) / 10 TABLET, CHEWABLE i... | Lanthanum Carbonate | Ascend Laboratories, LLC | 2025-05-10 |
| 68180-0819-42 | 2 BOTTLE in 1 PACKAGE (68180-819-42) / 45 TABLET, CHEWABLE... | Lanthanum Carbonate | Lupin Pharmaceuticals, Inc. | 2017-08-30 |
| 68180-0820-46 | 6 BOTTLE in 1 PACKAGE (68180-820-46) / 15 TABLET, CHEWABLE... | Lanthanum Carbonate | Lupin Pharmaceuticals, Inc. | 2017-08-30 |
| 68180-0821-47 | 9 BOTTLE in 1 PACKAGE (68180-821-47) / 10 TABLET, CHEWABLE... | Lanthanum Carbonate | Lupin Pharmaceuticals, Inc. | 2017-08-30 |
| 69097-0934-98 | 2 BOTTLE in 1 PACKAGE (69097-934-98) / 45 TABLET, CHEWABLE... | Lanthanum carbonate | Cipla USA Inc. | 2022-01-25 |
| 69097-0935-98 | 6 BOTTLE in 1 PACKAGE (69097-935-98) / 15 TABLET, CHEWABLE... | Lanthanum carbonate | Cipla USA Inc. | 2022-01-25 |
| 69097-0936-98 | 9 BOTTLE in 1 PACKAGE (69097-936-98) / 10 TABLET, CHEWABLE... | Lanthanum carbonate | Cipla USA Inc. | 2022-01-25 |
| 76282-0476-90 | 2 BOTTLE in 1 PACKAGE (76282-476-90) / 45 TABLET, CHEWABLE... | Lanthanum carbonate | Exelan Pharmaceuticals, Inc. | 2022-01-25 |
| 76282-0477-90 | 6 BOTTLE in 1 PACKAGE (76282-477-90) / 15 TABLET, CHEWABLE... | Lanthanum carbonate | Exelan Pharmaceuticals, Inc. | 2022-01-25 |
| 76282-0478-90 | 9 BOTTLE in 1 PACKAGE (76282-478-90) / 10 TABLET, CHEWABLE... | Lanthanum carbonate | Exelan Pharmaceuticals, Inc. | 2022-01-25 |
Observed labelers:
Takeda Pharmaceuticals America, Inc. (5) ·
Ascend Laboratories, LLC (3) ·
Cipla USA Inc. (3) ·
Exelan Pharmaceuticals, Inc. (3) ·
Lupin Pharmaceuticals, Inc. (3) ·
Prasco Laboratories (3)
· +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.